David R. Thomas, M.D., and John E. Morley, M.D.

During the last three years, Dr. Thomas has received grant/research support from Nestle. During the last three years, Dr. Morley has received grant/research support from Vivus, Merck & Co., Pharmacia, B. Braun McGaw, Bayer Corp and Nestec, Ltd. He has also served on the Speakers' Bureau for LXN, Organon, Ross, Pharmacia, GlaxoSmithKline, Aventis, Searle, Roche, Bristol-Myers Squibb, Novartis, Pratt, B.Braun McGaw, Pfizer and Solvay.

This Cyberounds^® is published simultaneously in the Supplement to the July 2002 issue of Annals of Long-Term Care, in cooperation with the Council for Nutritional Clinical Strategies in Long-Term Care, which received an unrestricted educational grant from Solvay Pharmaceuticals, Inc.

Release Date: 07/16/2002
Termination Date: 07/16/2005

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Upon completion of this Cyberounds^®, the participant should be able to:

• Discuss the high prevalence of malnutrition in older persons
• List the effects and side effects of different orexigenics
• Discuss the rationale for treating malnutrition in older persons.

 

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms of this CME activity